Dot1L-IN-2
Dot1L-IN-2 is a potent, selective and orally bioavailable inhibitor of Dot1L (a histone methyltransferase), with an IC50 and Ki of 0.4 nM and 0.08 nM, respectively.
Product Specifications
CAS Number
1940206-71-2
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Dot1L-IN-2.html
Solubility
10 mM in DMSO
Smiles
CN1C=NC2=CC(OC3=CC=CC=C3N4C(C)=CC5=C4C=C(NC6=NC=CC(NC)=N6)C=C5)=CN=C21
Molecular Formula
C27H24N8O
Molecular Weight
476.53
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362-P403+P233-P405-P501
References & Citations
[1]Chen C, et al. Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach. ACS Med Chem Lett. 2016 Jun 1;7 (8) :735-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DOT1L
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
EHF (ETS Homologous Factor, hEHF, ETS Domain-containing Transcription Factor, Epithelium-specific Ets Transcription Factor 3, ESE-3, ESE3, ESE3B, ESEJ) (Biotin)